[1]
“The Immunological Effect of a Gleevec Drug as Tyrosin Kinase Inhibitor in Auto-immune Thyroid Peroxidase in Iraqi Patientswith Chronic Myeloid Leukemia”, Iraqi Journal of Science, vol. 56, no. 4c, pp. 3399–3404, Mar. 2025, doi: 10.24996/ijs.2015.56.4c.%g.